[ORGANIZATION]
International Association for the Study of Lung Cancer
Featured in 2 tracked stories · first seen
Situations
Osimertinib efficacy and evolving NSCLC treatment trends
4 clusters · 18 sources · last updated
Latest: Italy advances cancer prevention and oncology treatments
Updated data from the Phase III ADAURA study, presented at the World Conference on Lung Cancer in Seoul, indicates that osimertinib provides sustained and clinically significant overall survival benefits for patients wit
Advancements in lung and breast cancer clinical trials
2 clusters · 13 sources · last updated
Latest: HER2-targeted antibody-drug conjugates show positive Phase III trial results
Recent clinical trial data presented at the IASLC 2026 World Conference on Lung Cancer and in the Journal of Clinical Oncology highlight significant advancements in oncology treatments, particularly regarding antibody-dr